Literature DB >> 24630972

Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury.

Ahdeah Pajoohesh-Ganji1, Mark P Burns2, Sonali Pal-Ghosh3, Gauri Tadvalkar3, Nicole G Hokenbury4, Mary Ann Stepp3, Alan I Faden5.   

Abstract

Amyloid-β (Aβ) is produced through the enzymatic cleavage of amyloid precursor protein (APP) by β (Bace1) and γ-secretases. The accumulation and aggregation of Aβ as amyloid plaques is the hallmark pathology of Alzheimer׳s disease and has been found in other neurological disorders, such as traumatic brain injury and multiple sclerosis. Although the role of Aβ after injury is not well understood, several studies have reported a negative correlation between Aβ formation and functional outcome. In this study we show that levels of APP, the enzymes cleaving APP (Bace1 and γ-secretase), and Aβ are significantly increased from 1 to 3 days after impact spinal cord injury (SCI) in mice. To determine the role of Aβ after SCI, we reduced or inhibited Aβ in vivo through pharmacological (using DAPT) or genetic (Bace1 knockout mice) approaches. We found that these interventions significantly impaired functional recovery as evaluated by white matter sparing and behavioral testing. These data are consistent with a beneficial role for Aβ after SCI.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid precursor protein; Amyloid-β; Bace1; Spinal cord injury; γ-Secretase

Mesh:

Substances:

Year:  2014        PMID: 24630972      PMCID: PMC4129635          DOI: 10.1016/j.brainres.2014.02.049

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  51 in total

1.  Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord.

Authors:  L Schnell; S Fearn; H Klassen; M E Schwab; V H Perry
Journal:  Eur J Neurosci       Date:  1999-10       Impact factor: 3.386

Review 2.  Advances in secondary spinal cord injury: role of apoptosis.

Authors:  J Lu; K W Ashwell; P Waite
Journal:  Spine (Phila Pa 1976)       Date:  2000-07-15       Impact factor: 3.468

3.  Detrimental effect of genetic inhibition of B-site APP-cleaving enzyme 1 on functional outcome after controlled cortical impact in young adult mice.

Authors:  Rebekah C Mannix; Jimmy Zhang; Juyeon Park; Christopher Lee; Michael J Whalen
Journal:  J Neurotrauma       Date:  2011-08-29       Impact factor: 5.269

4.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.

Authors:  D Michele Basso; Lesley C Fisher; Aileen J Anderson; Lyn B Jakeman; Dana M McTigue; Phillip G Popovich
Journal:  J Neurotrauma       Date:  2006-05       Impact factor: 5.269

5.  Novel neuroinflammatory targets in the chronically injured spinal cord.

Authors:  Ahdeah Pajoohesh-Ganji; Kimberly R Byrnes
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

6.  Secondary pathology following contusion, dislocation, and distraction spinal cord injuries.

Authors:  Anthony M Choo; Jie Liu; Marcel Dvorak; Wolfram Tetzlaff; Thomas R Oxland
Journal:  Exp Neurol       Date:  2008-05-14       Impact factor: 5.330

7.  Temporal-spatial expression of presenilin 1 and the production of amyloid-beta after acute spinal cord injury in adult rat.

Authors:  S Kobayashi; T Sasaki; T Katayama; T Hasegawa; A Nagano; K Sato
Journal:  Neurochem Int       Date:  2009-11-20       Impact factor: 3.921

8.  Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.

Authors:  Suzanne E Hickman; Elizabeth K Allison; Joseph El Khoury
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

9.  An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology.

Authors:  Dustin J Donnelly; John C Gensel; Daniel P Ankeny; Nico van Rooijen; Phillip G Popovich
Journal:  J Neurosci Methods       Date:  2009-04-23       Impact factor: 2.390

10.  Increased expression of the gamma-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injury.

Authors:  Yasmine Nadler; Alexander Alexandrovich; Nikolaos Grigoriadis; Tobias Hartmann; Kosagi S Jagannatha Rao; Esther Shohami; Reuven Stein
Journal:  Glia       Date:  2008-04       Impact factor: 7.452

View more
  11 in total

1.  Effects of the Notch Signaling Pathway on Secondary Brain Changes Caused by Spinal Cord Injury in Mice.

Authors:  Chengcai Li; Shaoxin Huang; Wu Zhou; Zhiping Xie; Shenke Xie; Meihua Li
Journal:  Neurochem Res       Date:  2022-02-24       Impact factor: 3.996

2.  Altered Neuroinflammation and Behavior after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease.

Authors:  Olga Kokiko-Cochran; Lena Ransohoff; Mike Veenstra; Sungho Lee; Maha Saber; Matt Sikora; Ryan Teknipp; Guixiang Xu; Shane Bemiller; Gina Wilson; Samuel Crish; Kiran Bhaskar; Yu-Shang Lee; Richard M Ransohoff; Bruce T Lamb
Journal:  J Neurotrauma       Date:  2015-11-23       Impact factor: 5.269

3.  Spinal cord injury and Alzheimer's disease risk: a population-based, retrospective cohort study.

Authors:  Tian-Shin Yeh; Yu-Chun Ho; Cherng-Lan Hsu; Shin-Liang Pan
Journal:  Spinal Cord       Date:  2017-10-23       Impact factor: 2.772

Review 4.  The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury.

Authors:  Bing Gong; Miroslav Radulovic; Maria E Figueiredo-Pereira; Christopher Cardozo
Journal:  Front Mol Neurosci       Date:  2016-01-26       Impact factor: 5.639

5.  Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Authors:  Jian-Ming Li; Li-Ling Huang; Fei Liu; Bei-Sha Tang; Xiao-Xin Yan
Journal:  BMC Neurol       Date:  2017-08-25       Impact factor: 2.474

Review 6.  The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.

Authors:  Holly M Brothers; Maya L Gosztyla; Stephen R Robinson
Journal:  Front Aging Neurosci       Date:  2018-04-25       Impact factor: 5.750

7.  Consequences of redefining Alzheimer's disease in terms of amyloid burden without regard to cognitive decline.

Authors:  Stephen R Robinson; Holly M Brothers; Maya L Gosztyla
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

8.  Low sulfated heparins target multiple proteins for central nervous system repair.

Authors:  George A McCanney; Michael A McGrath; Thomas D Otto; Richard Burchmore; Edwin A Yates; Charles D Bavington; Hugh J Willison; Jeremy E Turnbull; Susan C Barnett
Journal:  Glia       Date:  2018-12-26       Impact factor: 7.452

Review 9.  Multi-pathogen infections and Alzheimer's disease.

Authors:  Dana Vigasova; Michal Nemergut; Barbora Liskova; Jiri Damborsky
Journal:  Microb Cell Fact       Date:  2021-01-28       Impact factor: 5.328

Review 10.  The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics.

Authors:  Sarah A Kent; Tara L Spires-Jones; Claire S Durrant
Journal:  Acta Neuropathol       Date:  2020-07-29       Impact factor: 15.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.